Targeting Mitochondria 2019 Speakers

Mitochondrial genetics and Human Disease Douglas C. Wallace, Center for Mitochondrial and Epigenomic Medicine, USA	Mitochondria & Microbiota Inter-talk: Gut Microbiota inflence Mitochondria activity in patients Marvin Edeas, University Paris Descartes, INSERM U1016, France
The challenge of qualitative and quantitative assessment of mitochondrial function Egbert Mik, Erasmus MC, University Medical Center Rotterdam, The Netherlands	Increased Hydrogen Peroxide and decreased Glutathione Redox potential may cause Dopaminergic Neurodegeneration in Parkin loss-of-function Lori M. Buhlman, Midwestern University, USA
Stem Cell-driven Drug Discovery of OXPHOS Diseases Alessandro Prigione, Max Delbrueck Center for Molecular Medicine, Germany	Mitochondrial Copper Toxicity with a Focus on Wilson Disease Hans Zischka, Institute of Molecular Toxicology and Pharmacology, Germany
The brain MITOxy project : from mitochondria to proteases and reactive species interactome in brain Laurent Chatre, CNRS, University of Caen-Normandie, France	Mitochondrial Antioxidant Therapy for Treating Vascular Aging Douglas R Seals, University of Colorado Boulder, USA
Selective segregation of mitochondria in asymmetric stem cell divisions Pekka Katajisto, Center of Excellence in Stem Cell Metabolism, Finland	Mitochondrial Transplantation - From Animal Studies to Clinical Relevance James D. McCully, Harvard Medical School, Boston Children's Hospital, USA
Cardiac glycosides modulate neuroblastoma stem cell survival by dysfunctional mitophagy Marc Diederich, Seoul National University, South Korea	Mitochondria, as central regulators of neural stem cell fate Ruth Slacks, University of Ottawa, Canada
2,4-Dinitrophenol as Medicine John G. Geisler, Mitochon Pharmaceuticals, Inc, USA	Host mitochondria influence gut microbiome diversity: A role for ROS Tal Yardeni, Children's Hospital of Philadelphia, USA
The cellular stress protein MNRR1/CHCHD2 and mitochondrial disease Lawrence Grossman, Wayne State University, USA	Mitochondria-targeted low-molecular weight compounds for probing mitochondrial functions Richard C. Hartley, University of Glasgow, United Kingdom
Mitochondria-targeted Nanocarriers for mitochondrial therapies Shanta Dhar, University of Miami, USA	Roles for mitochondrial dysfunction in Alzheimer’s disease Benedict C. Albensi, Max Rady College of Medicine - University of Manitoba, Canada
Role of PGC-1s in human epidermal physiology Sibylle Jäger, L’Oréal Research & Innovation, France	Introduction: Role of actin-regulating proteins on mitochondria Cartrsten Culmsee, University of Marburg, Germany
Mitochondria and Skin: Mitochondria in Wound Healing Jakob Wikström, Karolinska University Hospital, Sweden	Cytoskeletal mitochondrial interactions in collagen VI related disorders Alessia Angelin, Children's Hospital of Philadelphia, USA
Mitochondrial reactive oxygen species in heart failure Christoph Maack, University Hospital Würzburg, Germany	Cannabinoids and skin: The "c(ut)annabinoid" system as a novel player in regulating cutaneous mitochondrial biology Attila Oláh, University of Debrecen, Hungary